Drug intelligence / Profile preview

lidocaine + tetracaine

Development stage
Approved
Lead developer
Galen
Modality
Small Molecules
Administration
Topical, Transdermal
01

Overview

Lidocaine + tetracaine is a fixed-dose combination of two local anesthetics used topically to numb the skin before minor medical or cosmetic procedures, such as blood draws, IV insertions, skin biopsies, laser treatments, dermal filler injections, and tattoo removal[1][3][4][5]. Both components act by blocking sodium channels in neuronal membranes (sodium channel antagonists), thereby inhibiting nerve impulse conduction and producing localized loss of sensation without causing unconsciousness[1][6]. The combination is available as a prescription-only cream or patch. It was originally developed by ZARS and has been further developed or marketed by companies including Crescita Therapeutics, Galderma, and Nuvo Research[6].

Brand names
SyneraPliaglisNynutey CreamNoliraFlexicaineS-Caine Peel
Other names
lidocaine and tetracaine topical creamtetracaine/lidocaine topical cream
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on lidocaine + tetracaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + tetracaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call